The Zucker Institute for Innovation Commercialization - powered by MUSC

Zucker Institute for Innovation Commercialization

Providing world-class commercialization leadership to maximize the impact of MUSC innovations. 

The Zucker Institute to Date

2,000 +

Innovations Supported

$4.22 M

Given Directly Back to Inventors

500 +

Patents Used

$6.45 M

Distributed to MUSC to Support Research

About the Zucker Institute

The Zucker Institute for Innovation Commercialization is responsible for evaluating all intellectual assets the enterprise owns and generates, cultivating value and forging industry and other relationships resulting in products and services that provide real-life solutions to the world’s medical needs.

Acting as a component of the Office of Innovation, we lead the commercialization of IP-backed innovations from the Medical University of South Carolina.

To date, companies developing products from the Zucker Institute have raised over $774M in capital. The Zucker Institute has filed over 2000 patent applications on behalf of more than 2000 MUSC Inventors/Creators.

View the most recent board agenda here.

Portfolio of Startup Companies

Wooden blocks stacked on a table. Painted on the blocks is an image of a rocket ship blasting off. A hand can be seen stacking the last block on top.MUSC’s portfolio of companies are advancing innovations in research, education, and health care, including novel therapeutics, devices, diagnostics, biologicals, healthcare IT and services. Combined, MUSC startups have raised over $50 million dollars in financing.

MUSC recognizes that the translation of discoveries has a significant benefit for society and is an important component of our mission as an academic medical center. Since 2014 over 70 startup companies have spun out of MUSC, and over half remain active today. Startups are an excellent approach to translate innovations into products and services for the public benefit and provide an engine for economic growth in the state. They also offer a means of commercialization that isn't always possible through licensing each technology separately.

Portfolio of Companies

View our portfolio of startup companies: